BLCO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Bausch + Lomb Corp (BLCO) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong revenue growth, improving financials, bullish technical indicators, and positive analyst sentiment make it a compelling choice. Despite the lack of recent news or significant hedge fund/insider activity, the overall outlook is favorable for long-term growth.
The technical indicators are bullish. The MACD histogram is positive at 0.165, indicating upward momentum. The RSI is at 77.757, which is in the neutral zone. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above its pivot level (17.664), with resistance levels at 18.682 and 19.311.
Strong Q4 2025 financial performance with 9.77% YoY revenue growth and significant improvement in net income and EPS.
Bullish technical indicators.
Positive analyst sentiment with multiple price target upgrades and Buy ratings.
Lack of recent news or event-driven catalysts.
Neutral sentiment from hedge funds and insiders.
No recent congress trading data.
In Q4 2025, revenue increased by 9.77% YoY to $1.405 billion. Net income improved significantly to -$58 million (up 1833.33% YoY), and EPS increased by 1500% YoY to -0.16. Gross margin improved to 58.08%, up 4.55% YoY.
Analysts are generally positive on BLCO. Recent upgrades include H.C. Wainwright raising the price target to $20 with a Buy rating and Citi raising the target to $21 with a Buy rating. However, some analysts maintain Hold or Underperform ratings due to concerns about Bausch Health's separation and market uncertainties.
